Literature DB >> 12824523

Generation and characterization of p53 mutant mice.

Melissa L Dumble1, Lawrence A Donehower, Xiongbin Lu.   

Abstract

p53 is one of the most well-characterized members of the tumor suppressor gene family. The role of p53 in controlling cellular homeostasis has proven critical, with over half of all human tumors having either lost or mutated p53. The emergence of technology facilitating the ablation of a gene within an animal's genome allowed great advances in the study of p53. The p53 knockout mouse was one of the first of its kind and provided a powerful tool for the study of p53. Production of the p53 knock-out mouse demonstrated the protein's dispensability during embryogenesis, while highlighting its essential role in controlling tumor formation. A variety of p53 mutant models have emerged since the original p53 knock-out mouse, along with improved techniques for regulating gene targeting. This chapter describes the necessary steps and protocols involved in producing a mutant mouse as well as the characterization that follows.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824523     DOI: 10.1385/1-59259-408-5:29

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.

Authors:  Neha Parikh; Ryan L Shuck; Thuy-Ai Nguyen; Alan Herron; Lawrence A Donehower
Journal:  Mol Cancer Res       Date:  2012-04-24       Impact factor: 5.852

2.  Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant mice.

Authors:  Karin Heby-Henricson; Asa Bergström; Björn Rozell; Rune Toftgård; Stephan Teglund
Journal:  Mol Carcinog       Date:  2011-08-31       Impact factor: 4.784

3.  Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.

Authors:  Jun Wang; Tao Shen; Wuqiang Zhu; Longyu Dou; Hao Gu; Lingling Zhang; Zhenyun Yang; Hanying Chen; Qi Zhou; Edwin R Sánchez; Loren J Field; Lindsey D Mayo; Zhongwen Xie; Deyong Xiao; Xia Lin; Weinian Shou; Weidong Yong
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

Review 4.  Drug targeting of dysregulated transcription in Huntington's disease.

Authors:  Aleksey G Kazantsev; Steven M Hersch
Journal:  Prog Neurobiol       Date:  2007-02-23       Impact factor: 11.685

5.  NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.

Authors:  S Zhao; L Kurenbekova; Y Gao; A Roos; C J Creighton; P Rao; J Hicks; T-K Man; C Lau; A M C Brown; S N Jones; A J Lazar; D Ingram; D Lev; L A Donehower; J T Yustein
Journal:  Oncogene       Date:  2015-01-12       Impact factor: 9.867

6.  The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development.

Authors:  Xinglu Huang; Fan Zhang; Xiaolian Sun; Ki-Young Choi; Gang Niu; Guofeng Zhang; Jinxia Guo; Seulki Lee; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2014-01       Impact factor: 12.479

7.  Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.

Authors:  Wendy Allen-Rhoades; Lyazat Kurenbekova; Laura Satterfield; Neha Parikh; Daniel Fuja; Ryan L Shuck; Nino Rainusso; Matteo Trucco; Donald A Barkauskas; Eunji Jo; Charlotte Ahern; Susan Hilsenbeck; Lawrence A Donehower; Jason T Yustein
Journal:  Cancer Med       Date:  2015-03-17       Impact factor: 4.452

8.  Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression.

Authors:  George Hinkal; Neha Parikh; Lawrence A Donehower
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.